List of Contents

Pharmaceutical Logistics Market Size, Share, and Trends 2024 to 2034

The global pharmaceutical logistics market size is predicted to increase from USD 94.26 billion in 2024, grew to USD 102.56 billion in 2025 and is anticipated to reach around USD 219.1 billion by 2034, poised to grow at a CAGR of 8.80% between 2024 and 2034.

  • Last Updated : October 2024
  • Report Code : 1443
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pharmaceutical Logistics Market 

5.1. COVID-19 Landscape: Pharmaceutical Logistics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pharmaceutical Logistics Market, By Type

8.1. Pharmaceutical Logistics Market, by Type, 2024-2034

8.1.1. Cold Chain Logistics

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Non-cold Chain Logistics

8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Pharmaceutical Logistics Market, By Component

9.1. Pharmaceutical Logistics Market, by Component, 2024-2034

9.1.1. Storage

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Transportation

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Monitoring components

9.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Pharmaceutical Logistics Market, By Application Type 

10.1. Pharmaceutical Logistics Market, by Application Type, 2024-2034

10.1.1. Bio Pharma

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Chemical Pharma

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Speciality Pharma

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Pharmaceutical Logistics Market, By Procedure Type 

11.1. Pharmaceutical Logistics Market, by Procedure Type, 2024-2034

11.1.1. Picking

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Storage

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Retrieval Systems

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Handling Systems

11.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Pharmaceutical Logistics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Component (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Component (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Application Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by Procedure Type (2021-2034)

Chapter 13. Company Profiles

13.1. FedEx

13.1.1. Company Overview

13.1.2. Product Offering

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Agility

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. CEVA Logistics

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Deutsche Post AG

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. VersaCold Logistics Services

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. LifeConEx

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Air Canada

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. United Parcel Service of America Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. DB Schenker

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Marken

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client